HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 8.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 251,277 shares of the company’s stock after buying an additional 18,747 shares during the quarter. Canada Pension Plan Investment Board owned 0.10% of HCA Healthcare worth $80,730,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Unique Wealth Strategies LLC acquired a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $28,000. Bangor Savings Bank raised its holdings in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares during the period. GPS Wealth Strategies Group LLC increased its position in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares in the last quarter. Finally, LifeSteps Financial Inc. acquired a new stake in HCA Healthcare in the 1st quarter valued at $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock worth $6,407,273 over the last 90 days. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the topic of several research analyst reports. Royal Bank of Canada lifted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Robert W. Baird began coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price target on the stock. Finally, Barclays increased their price objective on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Stock Up 0.2 %

Shares of NYSE HCA opened at $404.37 on Friday. The stock has a market cap of $105.91 billion, a PE ratio of 20.16, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $405.70. The business has a 50-day moving average price of $370.57 and a 200 day moving average price of $340.59. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The business had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s revenue was up 10.3% compared to the same quarter last year. During the same period in the prior year, the company earned $4.29 earnings per share. Equities research analysts forecast that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.65%. HCA Healthcare’s payout ratio is currently 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.